Anti-DPEP3 Reference Antibody (tamrintamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Anti-SLC34A2 Reference Antibody (lifastuzumAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.